PDS Biotechnology Corporation Profile Avatar - Palmy Investing

PDS Biotechnology Corporation

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment fo…

Biotechnology
US, Florham Park [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of PDSB's Analysis
CIK: 1472091 CUSIP: 70465T107 ISIN: US70465T1079 LEI: - UEI: -
Secondary Listings
PDSB has no secondary listings inside our databases.